Annovis Bio
ANVS
ANVS
42 hedge funds and large institutions have $3.93M invested in Annovis Bio in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 44 → 42 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Holders
42
Holding in Top 10
–
Calls
$306K
Puts
$260K
Top Buyers
| 1 | +$197K | |
| 2 | +$106K | |
| 3 | +$80K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$66.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$63.6K |
Top Sellers
| 1 | -$292K | |
| 2 | -$249K | |
| 3 | -$139K | |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$58.5K |
| 5 |
BlackRock
New York
|
-$43.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – |
|
|||
|
TRCT
52
Tower Research Capital (TRC)
New York
| – |
|
|||
|
GPFA
53
Game Plan Financial Advisors
Westlake,
Ohio
| – |
|